PIRAMAL ENTERPRISES LTD. - 500302 - Announcement under Regulation 30 (LODR)-Meeting Updates
Regulations 29 & 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201502-11-2022
02-11-2022
PIRAMAL ENTERPRISES LTD. - 500302 - Board Meeting Intimation for Board Meeting Intimation For Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
PIRAMAL ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2022. In this regard, we write to inform you that the 'Trading Window' for dealing in the securities of the Company has been closed from Saturday, 1st October, 2022 and will remain closed till Friday, 11th November, 2022 (both days inclusive).02-11-2022
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201502-11-2022
PIRAMAL ENTERPRISES LTD. - 500302 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 - Appointment of Independent Director31-10-2022
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201531-10-2022
MSCI sets aside Piramal Pharma's exclusion from global standard index
The company was listed separately on October 19, following its demerger from Piramal Enterprises27-10-2022
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201522-10-2022
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201520-10-2022
Piramal Pharma lists at Rs 202 on BSE; shares tumble 5% intra-day
In October 2021, the board of directors of Piramal Enterprises (PEL) had approved the demerger of the pharmaceuticals business, and simplification of the corporate structure19-10-2022
PIRAMAL ENTERPRISES LTD. - 500302 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201517-10-2022